Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natasha Sansone"'
Autor:
Louis Shekhtman, Miquel Navasa, Natasha Sansone, Gonzalo Crespo, Gitanjali Subramanya, Tje Lin Chung, E Fabian Cardozo-Ojeda, Sofía Pérez-del-Pulgar, Alan S Perelson, Scott J Cotler, Xavier Forns, Susan L Uprichard, Harel Dahari
Publikováno v:
eLife, Vol 10 (2021)
While the liver, specifically hepatocytes, are widely accepted as the main source of hepatitis C virus (HCV) production, the role of the liver/hepatocytes in clearance of circulating HCV remains unknown. Frequent HCV kinetic data were recorded and ma
Externí odkaz:
https://doaj.org/article/88ec9d007d544a56ba1441581f7bf611
Autor:
Gonzalo Crespo, E Fabian Cardozo-Ojeda, Louis M. Shekhtman, Scott J. Cotler, Harel Dahari, Xavier Forns, Natasha Sansone, Susan L. Uprichard, Alan S. Perelson, Gitanjali Subramanya, Miquel Navasa, Tje Lin Chung, Sofía Pérez-del-Pulgar
Publikováno v:
eLife
eLife, Vol 10 (2021)
eLife, Vol 10 (2021)
While the liver, specifically hepatocytes, are widely accepted as the main source of hepatitis C virus (HCV) production, the role of the liver/hepatocytes in clearance of circulating HCV remains unknown. Frequent HCV kinetic data were recorded and ma
Autor:
Gonzalo Crespo, Susan L. Uprichard, E Fabian Cardozo-Ojeda, Scott J. Cotler, Miquel Navasa, Natasha Sansone, Alan S. Perelson, Louis M. Shekhtman, Xavier Forns, Tje Lin Chung, Harel Dahari, Sofía Pérez-del-Pulgar, Gitanjali Subramanya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4729fc6d536615ccd453f65a52d99f69
https://doi.org/10.7554/elife.65297.sa2
https://doi.org/10.7554/elife.65297.sa2
Autor:
Tje Lin Chung, Susan L. Uprichard, Alan S. Perelson, Natasha Sansone, Xavier Forns, Scott J. Cotler, Miquel Navasa, Louis M. Shekhtman, Sofía Pérez-del-Pulgar, Gitanjali Subramanya, Gonzalo Crespo, Harel Dahari
While the liver, specifically hepatocytes, are widely accepted as the main source for hepatitis C virus (HCV) production, the role of the liver/hepatocytes in the clearance of circulating HCV remains largely unknown. Here we evaluated the function of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::543102bd877e5845680be4b0ad90d905
https://doi.org/10.1101/2020.08.03.20167387
https://doi.org/10.1101/2020.08.03.20167387
Autor:
Scott J. Cotler, Natasha Sansone, Harel Dahari, Libin Rong, Alan S. Perelson, Jeremie Guedj, Susan L. Uprichard, Thomas J. Layden, Richard E. Nettles
Publikováno v:
Proceedings of the National Academy of Sciences. 110:3991-3996
The nonstructural 5A (NS5A) protein is a target for drug development against hepatitis C virus (HCV). Interestingly, the NS5A inhibitor daclatasvir (BMS-790052) caused a decrease in serum HCV RNA levels by about two orders of magnitude within 6 h of